Literature DB >> 29458199

Alpha-synuclein oligomers impair memory through glial cell activation and via Toll-like receptor 2.

Pietro La Vitola1, Claudia Balducci1, Milica Cerovic1, Giulia Santamaria1, Edoardo Brandi1, Federica Grandi1, Laura Caldinelli2, Laura Colombo3, Maria Grazia Morgese4, Luigia Trabace4, Loredano Pollegioni2, Diego Albani1, Gianluigi Forloni5.   

Abstract

Alpha-synuclein oligomers (α-synOs) are emerging as crucial factors in the pathogenesis of synucleinopathies. Although the connection between neuroinflammation and α-syn still remains elusive, increasing evidence suggests that extracellular moieties activate glial cells leading to neuronal damage. Using an acute mouse model, we explored whether α-synOs induce memory impairment in association to neuroinflammation, addressing Toll-like receptors 2 and 4 (TLR2 and TLR4) involvement. We found that α-synOs abolished mouse memory establishment in association to hippocampal glial activation. On brain slices α-synOs inhibited long-term potentiation. Indomethacin and Ibuprofen prevented the α-synOs-mediated detrimental actions. Furthermore, while the TLR2 functional inhibitor antibody prevented the memory deficit, oligomers induced memory deficits in the TLR4 knockout mice. In conclusion, solely α-synOs induce memory impairment likely inhibiting synaptic plasticity. α-synOs lead to hippocampal gliosis that is involved in memory impairment. Moreover, while the oligomer-mediated detrimental actions are TLR2 dependent, the involvement of TLR4 was ruled out.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anti-inflammatory drugs; Lewy bodies dementia; Neuroinflammation; Oligomeropathies; Parkinson; Synucleopathies; Toll-like receptors

Mesh:

Substances:

Year:  2018        PMID: 29458199     DOI: 10.1016/j.bbi.2018.02.012

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  17 in total

1.  Extracellular α-Synuclein Modulates Iron Metabolism Related Proteins via Endoplasmic Reticulum Stress in MES23.5 Dopaminergic Cells.

Authors:  Xiaoqing Mi; Qijun Li; Xiaoming Wen; Junxia Xie; Youcui Wang; Ning Song
Journal:  Neurochem Res       Date:  2021-03-11       Impact factor: 3.996

2.  Interferon-γ Potentiates α-Synuclein-induced Neurotoxicity Linked to Toll-like Receptors 2 and 3 and Tumor Necrosis Factor-α in Murine Astrocytes.

Authors:  Jintang Wang; Zheng Chen; Jeremy D Walston; Peisong Gao; Maolong Gao; Sean X Leng
Journal:  Mol Neurobiol       Date:  2019-05-16       Impact factor: 5.590

Review 3.  Targeting Microglial and Neuronal Toll-like Receptor 2 in Synucleinopathies.

Authors:  Somin Kwon; Michiyo Iba; Eliezer Masliah; Changyoun Kim
Journal:  Exp Neurobiol       Date:  2019-10-31       Impact factor: 3.261

Review 4.  Pharmacological Targeting of Microglial Activation: New Therapeutic Approach.

Authors:  Cai-Yun Liu; Xu Wang; Chang Liu; Hong-Liang Zhang
Journal:  Front Cell Neurosci       Date:  2019-11-19       Impact factor: 5.505

5.  TLR7/8 in the Pathogenesis of Parkinson's Disease.

Authors:  Michela Campolo; Alessia Filippone; Carmelo Biondo; Giuseppe Mancuso; Giovanna Casili; Marika Lanza; Salvatore Cuzzocrea; Emanuela Esposito; Irene Paterniti
Journal:  Int J Mol Sci       Date:  2020-12-09       Impact factor: 5.923

Review 6.  Experimental Models of Cognitive Impairment for Use in Parkinson's Disease Research: The Distance Between Reality and Ideal.

Authors:  Yaohua Fan; Jiajun Han; Lijun Zhao; Chunxiao Wu; Peipei Wu; Zifeng Huang; Xiaoqian Hao; YiChun Ji; Dongfeng Chen; Meiling Zhu
Journal:  Front Aging Neurosci       Date:  2021-11-29       Impact factor: 5.750

7.  Hypomyelinating Leukodystrophy 8 (HLD8)-Associated Mutation of POLR3B Leads to Defective Oligodendroglial Morphological Differentiation Whose Effect Is Reversed by Ibuprofen.

Authors:  Sui Sawaguchi; Rimi Suzuki; Hiroaki Oizumi; Katsuya Ohbuchi; Kazushige Mizoguchi; Masahiro Yamamoto; Yuki Miyamoto; Junji Yamauchi
Journal:  Neurol Int       Date:  2022-02-16

8.  MicroRNA-7, synergizes with RORα, negatively controls the pathology of brain tissue inflammation.

Authors:  Dongxu Yue; Juanjuan Zhao; Huizi Chen; Mengmeng Guo; Chao Chen; Ya Zhou; Lin Xu
Journal:  J Neuroinflammation       Date:  2020-01-20       Impact factor: 8.322

9.  Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers.

Authors:  Laura Boi; Augusta Pisanu; Maria Francesca Palmas; Giuliana Fusco; Ezio Carboni; Maria Antonietta Casu; Valentina Satta; Maria Scherma; Elzbieta Janda; Ignazia Mocci; Giovanna Mulas; Anna Ena; Saturnino Spiga; Paola Fadda; Alfonso De Simone; Anna R Carta
Journal:  Int J Mol Sci       Date:  2020-11-12       Impact factor: 5.923

10.  Metabolomics Fingerprint Induced by the Intranigral Inoculation of Exogenous Human Alpha-Synuclein Oligomers in a Rat Model of Parkinson's Disease.

Authors:  Federica Murgia; Luigi Atzori; Ezio Carboni; Maria Laura Santoru; Aran Hendren; Augusta Pisanu; Pierluigi Caboni; Laura Boi; Giuliana Fusco; Anna R Carta
Journal:  Int J Mol Sci       Date:  2020-09-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.